Results 161 to 170 of about 10,595 (215)

Adenoviral Vectors Expressing Optimized preM/E Genes of WNV Deliver Long-Term Protection Against Lethal West Nile Virus Challenge. [PDF]

Vaccines (Basel)
Ozharovskaia TA, Zubkova OV, Korobova EV, Dolzhikova IV, Zrelkin DI, Popova O, Goldovskaya PP, Kovyrshina AV, Korobkova AI, Favorskaya IA, Vavilova IV, Grousova DM, Zorkov ID, Iliukhina AA, Ermolova IA, Tukhvatulin AI, Shcherbinin DN, Ermolova EI, Kunda MS, Ryzhova NN, Voronina OL, Semikhin AS, Shcheblyakov DV, Logunov DY, Gintsburg AL.   +24 more
europepmc   +1 more source

The validity of test-negative design for assessment of typhoid conjugate vaccine protection: comparison of estimates by different study designs using data from a cluster-randomised controlled trial.

Lancet Glob Health
Feng S, Zhang Y, Khanam F, Voysey M, Pitzer VE, Qadri F, Clemens JD, Pollard AJ, Liu X.   +8 more
europepmc   +1 more source

Japanese encephalitis vaccines.

Releve epidemiologique hebdomadaire, 2006
openaire   +1 more source

National burden and optimal vaccine policy for Japanese encephalitis virus in Bangladesh

Perez Duque M, Paul KK, Sultana R, Ribeiro dos Santos G, O’Driscoll M, Naser AM, Rahman M, Alam MS, Al-Amin HM, Rahman MZ, Hossain ME, Paul RC, Krainski E, Luby SP, Cauchemez S, Vanhomwegen J, Gurley ES, Salje H.   +17 more
europepmc   +1 more source

Japanese encephalitis vaccines.

Releve epidemiologique hebdomadaire, 1999
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Japanese encephalitis vaccine

Reactions Weekly, 2021
Travelers to 24 endemic countries in Asia may be at risk for Japanese encephalitis. The ACIP has recently expanded guidelines on the use of Ixiaro, the inactivated Japanese encephalitis vaccine. This article reviews the disease burden of Japanese encephalitis and the role of a travel clinic in guiding travelers to Asia regarding decision-making about ...
  +5 more sources

IC51 Japanese Encephalitis vaccine

Expert Opinion on Biological Therapy, 2009
Japanese encephalitis is the leading cause of viral encephalitis in Asia. Every year 30,000 - 50,000 cases and 10,000 deaths from Japanese encephalitis are reported, and underreporting has been suggested. No effective antiviral therapy exists to treat this mosquito-borne flavivirus infection. For active immunization vaccines are available.
Herwig, Kollaritsch, Maria, Paulke-Korinek, Katrin, Dubischar-Kastner   +2 more
openaire   +2 more sources

[Japanese encephalitis vaccine].

Nihon rinsho. Japanese journal of clinical medicine, 2011
Japanese encephalitis is a mosquito-borne flaviviral infection, which has a wide distribution in Asian countries, including Japan. The clinical illness may manifest as a febrile headache syndrome, aseptic meningitis, or encephalitis with a number of cases of subclinical infection. Japanese encephalitis is a vaccine-preventable disease.
openaire   +3 more sources